NPI registry status
Active
2026 NPPES data Neuromuscular Medicine (Psychiatry & Neurology) Physician NPI 1861620924 MD
Verify on CMS → Baijayanta Maiti, MD
Neuromuscular Medicine (Psychiatry & Neurology) Physician in Saint Louis, Missouri.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 338 in Neuromuscular Medicine (Psychiatry & Neurology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
828
Medicare Part D claims · 90 beneficiaries · Neuromuscular Medicine (Psychiatry & Neurology) Physician avg: 931
Generic prescribing
99%
generic claims · 1% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
79.3/100
▼ 4 pts below national avg 83.1 · Above neutral
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Baijayanta Maiti, MD reported a CMS MIPS final score of 79.3/100 - below the 83.1 national average - and filed 828 Medicare Part D claims in 2023.
- 79.3/100
- MIPS score · -4 vs avg
- 828
- Part D claims, 2023
- 99%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Baijayanta Maiti, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
79 30th percentile higher than 30% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Baijayanta Maiti, MD sits
This provider among neuromuscular medicine (psychiatry & neurology) physician peers
Across the 132 neuromuscular medicine (psychiatry & neurology) physician providers who report both Medicare Part D prescribing and a MIPS quality score, Baijayanta Maiti, MD writes more Part D claims than 58% of them and scores higher on MIPS quality than 31% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one neuromuscular medicine (psychiatry & neurology) physician peer from a representative sample of 60; the gold marker is Baijayanta Maiti, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Baijayanta Maiti, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Baijayanta Maiti, MD?
Near national averagePrimary specialty
Neuromuscular Medicine (Psychiatry & Neurology) Physician
Medicare Part D claims
828 11% vs specialty avg
MIPS final score
79.3/100 3.8 pts vs avg
Specialty distribution in Missouri
How Neuromuscular Medicine (Psychiatry & Neurology) Physician compares to other specialties among Missouri providers
Medicare quality performance, MIPS
Baijayanta Maiti, MD's 2023 MIPS final score plotted against the Neuromuscular Medicine (Psychiatry & Neurology) Physician national average
- MIPS Final Score
- 79.3/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Neuromuscular Medicine (Psychiatry & Neurology) Physician) - 79.3/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Baijayanta Maiti, MD appears in the CMS NPPES registry as a Neuromuscular Medicine (Psychiatry & Neurology) Physician provider holding MD credentials at 4921 PARKVIEW PL, Saint Louis, MO, 63110, with a listed phone of (314) 362-6908. NPI 1861620924 was issued on 06/29/2009.
Medicare Part D records for calendar year 2023 show 828 prescription claims written by this provider, covering 90 Medicare beneficiaries and totaling roughly $130K in drug spend, split 1% brand-name and 99% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 79.3/100 for the 2023 performance year (Quality 71.5, Cost 59.5), compared with the national average of 83.1.
Neuromuscular Medicine (Psychiatry & Neurology) Physician is a narrow specialty nationwide, with 338 enrolled providers across 44 states and an average of 931 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1861620924 |
|---|---|
| Specialty | Neuromuscular Medicine (Psychiatry & Neurology) Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/29/2009 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
79.292
Final Score
Avg: 83.1
71.46
Quality
59.5132
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Baijayanta Maiti, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Washington University
Saint Louis, MO
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Generic-heavy
Baijayanta Maiti, MD - brand share 1.0%
Neuromuscular Medicine (Psychiatry & Neurology) Physician average
1% brand-name claims vs 99% generic, on 828 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
828
Total Claims
$130K
Total Drug Cost
90
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,621
- Total Day Supply
- 48,115
- Brand vs Generic
- 1% brand / 99% generic
- Brand Drug Cost
- $53K
- Generic Drug Cost
- $77K
Patient Demographics
- Average Patient Age
- 71.4 years
- Avg HCC Risk Score
- 1.65
- Gender Split
- 46% female / 54% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Baijayanta Maiti, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Carbidopa-Levodopa
Carbidopa-Levodopa
232 claims
- Duloxetine Hcl 77
Duloxetine Hcl
77 claims
- Gabapentin 76
Gabapentin
76 claims
- Carbidopa-Levodopa… 61
Carbidopa-Levodopa Er
61 claims
- Escitalopram Oxalate 38
Escitalopram Oxalate
38 claims
- Fludrocortisone Ac… 32
Fludrocortisone Acetate
32 claims
- Baclofen 29
Baclofen
29 claims
- Mirtazapine 29
Mirtazapine
29 claims
| Drug | Claims |
|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 232 |
| Duloxetine Hcl | 77 |
| Gabapentin | 76 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 61 |
| Escitalopram Oxalate | 38 |
| Fludrocortisone Acetate | 32 |
| Baclofen | 29 |
| Mirtazapine | 29 |
| Sertraline Hcl | 27 |
| Clonazepam | 25 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Neuromuscular Medicine (Psychiatry & Neurology) Physician in MO →
All providers in Missouri →
Compare specialties →
Neuromuscular Medicine (Psychiatry & Neurology) Physician Overview
How Baijayanta Maiti, MD fits within the Neuromuscular Medicine (Psychiatry & Neurology) Physician landscape nationally.
338
Neuromuscular Medicine (Psychiatry & Neurology) Physician Providers in US
44
States with Neuromuscular Medicine (Psychiatry & Neurology) Physician
931
Avg Claims per Provider
Baijayanta Maiti, MD's 828 claims are below the specialty average of 931.
Nearby Neuromuscular Medicine (Psychiatry & Neurology) Physician Providers in Missouri
Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as Maiti.
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Missouri medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Neuromuscular Medicine (Psychiatry & Neurology) Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Missouri
Frequently Asked Questions
What is Baijayanta Maiti, MD's specialty? ▼
Baijayanta Maiti, MD specializes in Neuromuscular Medicine (Psychiatry & Neurology) Physician and practices in Saint Louis, Missouri. Credentials: MD.
How much does Baijayanta Maiti, MD prescribe under Medicare Part D? ▼
In 2023, Baijayanta Maiti, MD wrote 828 Medicare Part D claims totaling $130K in drug costs for 90 beneficiaries.
What is Baijayanta Maiti, MD's Medicare quality score? ▼
Baijayanta Maiti, MD has a CMS MIPS Final Score of 79.3/100 (Quality: 71.5, Cost: 59.5). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Baijayanta Maiti, MD located? ▼
Baijayanta Maiti, MD is located at 4921 PARKVIEW PL, Saint Louis, MO, 63110. Phone: (314) 362-6908.
What is Baijayanta Maiti, MD's NPI number? ▼
Baijayanta Maiti, MD's National Provider Identifier (NPI) is 1861620924, issued on 06/29/2009.
Does Baijayanta Maiti, MD prescribe more brand-name or generic drugs? ▼
Baijayanta Maiti, MD's prescribing is 1% brand-name and 99% generic drugs by claim count, with $53K in brand drug costs.
How many Neuromuscular Medicine (Psychiatry & Neurology) Physician providers are there in the US? ▼
There are 338 Neuromuscular Medicine (Psychiatry & Neurology) Physician providers across 44 states in the US. The average Neuromuscular Medicine (Psychiatry & Neurology) Physician provider writes 931 Medicare Part D claims per year.
What drugs does Baijayanta Maiti, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Baijayanta Maiti, MD's most frequently prescribed drugs include Carbidopa-Levodopa, Duloxetine Hcl, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Baijayanta Maiti, MD accept Medicare? ▼
Baijayanta Maiti, MD appears in CMS Medicare data with 828 Part D claims and 90 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Baijayanta Maiti, MD's credentials? ▼
Baijayanta Maiti, MD's NPI is 1861620924 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.